Use LEFT and RIGHT arrow keys to navigate between flashcards;
Use UP and DOWN arrow keys to flip the card;
H to show hint;
A reads text to speech;
17 Cards in this Set
- Front
- Back
|
The most common anticoagulant for apheresis procedures is:
|
Citrate |
|
|
Therapeutic cytapheresis has a primary role in the treatment of patients with:
|
sickle cell disease and acute chest syndrome
|
|
|
The minimum interval allowed between plateletphersis component collection procedures is: |
2 days |
|
|
In plasma exchange, the therapeutic effectiveness is: |
greatest with the first plasma volume removed. |
|
|
The replacement fluid indicated during plasma exchange for TTP is: |
FFP |
|
|
The most common adverse effect of plateletpheresis collection is: |
citrate effect |
|
|
Apheresis technology can be used to collect: |
leukocytes, hematopoietic progenitor cells, and platelets |
|
|
The anticoagulant added to blood as it is removed from a donor or patient during an apheresis procedure acts by: |
binding calcium ions |
|
|
Peripheral blood stem cells are: |
pluripotential hematopoietic precursors that circulate in the peripheral blood
|
|
|
What can be given to an apheresis donor to increase the number of circulation granulocytes? |
G-CSF |
|
|
In an ____________ procedure, blood is withdrawn from a donor or patient and separated into its components. One or more components is retained and the remaining components are recombined and returned to the individual. |
apheresis |
|
|
Apheresis equipment that uses intermittent flow centrifugation (IFC) uses ___________ venipuncture. |
one
|
|
|
Continuous flow centrifugation (CFC) procedures withdraw, process, and return the blood to the individual simultaneously. ______ venipuncture sites are necessary. |
Two
|
|
|
Membrane filtration technology uses membranes with specific pore sizes, allowing _____________ to pass through the membrane while the cellular portion passes over it. |
plasma
|
|
|
The most common anticoagulant used in apheresis is ____________________________. |
acid citrate dextrose
|
|
|
In _________________ plasmapheresis procedures, the replacement fluids used to maintain appropriate intravascular volume and oncotic pressure include normal saline, FFP, cryo-reduced plasma and 5% human serum albumin. |
therapeutic
|
|
|
Complications of ___________________ include vascular access issues, alteration of pharmacodynamics of medications, citrate toxicity, fluid imbalance, allergic reactions, equipment malfunction and infection. |
apheresis |
